Pacific Edge receives approval for new CPT codes from AMA

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), advises that the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel has granted Administrative MAAA CPT codes for Pacific Edge’s Cxbladder Detect and Cxbladder Monitor tests.

The granting of these dedicated codes is a key component of the reimbursement process in the US and will help with access to the Cxbladder tests for urologists and their patients across the United States.

“The CPT Category Administrative MAAA code approval is recognition by the leading panel of medical experts in the United States that the Cxbladder tests are now established diagnostic tests addressing an important unmet medical need,” said Jackie Walker, CEO of Pacific Edge Diagnostics USA Ltd.

“The multiple peer-reviewed clinical studies and the growing adoption of the tests in the United States were key factors in the decision by the CPT Editorial Board reviewers.”

CEO of Pacific Edge, David Darling, commented: “This positive reimbursement code award continues to reflect the growing acceptance of Cxbladder as effective, non-invasive and highly accurate tests for the detection and improved management of urothelial cancer. Having unique codes in place will facilitate reimbursement for Cxbladder in the US, minimising barriers for urologists who order Cxbladder tests for their patient care.”